Endotoxin Markers in Bronchoalveolar Lavage Fluid of Patients with Interstitial Lung Diseases

Overview

Journal Multidiscip Respir Med

Specialty Pulmonary Medicine

Date 2012 Dec 25

PMID 23259971

Citations 1

Authors

Bogumila Szponar

Lennart Larsson

Joanna Domagala-Kulawik

Affiliations

Soon will be listed here.

Abstract

Unlabelled:

Background: Exposure to inhaled endotoxins (lipopolysaccharides, LPS) of Gram-negative bacteria commonly found in indoor environments and assessed in secondary tobacco smoke, has been associated with airway inflammation and asthma exacerbation. The bronchoalveolar lavage fluid (BALf) from patients with interstitial lung diseases (sarcoidosis, lung fibrosis, smoking-related ILD, eosinophilic disorders) was analyzed for the markers of lipopolysaccharide (LPS, endotoxin).

Methods: BALf was obtained from patients with diffuse lung diseases: idiopathic pulmonary fibrosis (n = 42), sarcoidosis (n = 22), smoking-related-ILD (n = 11) and eosinophilic disorders (n = 8). Total cell count and differential cell count were performed. In addition, samples were analyzed for 3-hydroxy fatty acids (3-OHFAs) of 10-18 carbon chain lengths, as markers of LPS, by gas chromatography-tandem mass spectrometry.

Results: The highest LPS concentration was found in patients with eosinophilic disorders and the lowest in patients with sarcoidosis (p< 0.05) followed by the lung fibrosis and the sr-ILD patients. The difference between LPS in BALf with extremely high eosinophil proportion (> 25%) and those with lower proportion was also significant (p = 0.014). A significant correlation was found between LPS and eosinophils, but not between LPS and lymphocytes, neutrophils, or macrophages count.

Conclusions: A positive relationship of LPS and eosinophilic pulmonary disorders may be linked to a persistent eosinophil activation mediated by Th2 pathway: chronic endotoxin exposure would intensify Th2 pathway resulting in fibrosis and, at the same time, eosinophil stimulation, and hence in eosinophilic pulmonary disorders.

Citing Articles

Obesity-associated cancer risk: the role of intestinal microbiota in the etiology of the host proinflammatory state.

Djuric Z Transl Res. 2016; 179():155-167.

PMID: 27522986 PMC: 5164980. DOI: 10.1016/j.trsl.2016.07.017.

References

Borchers A, So C, Naguwa S, Keen C, Gershwin M . Clinical and immunologic components of sarcoidosis. Clin Rev Allergy Immunol. 2004; 25(3):289-303. DOI: 10.1385/CRIAI:25:3:289. View

Seibold M, Schwartz D . The lung: the natural boundary between nature and nurture. Annu Rev Physiol. 2010; 73:457-78. DOI: 10.1146/annurev-physiol-012110-142212. View

Wallin A, Pourazar J, Sandstrom T . LPS-induced bronchoalveolar neutrophilia; effects of salmeterol treatment. Respir Med. 2004; 98(11):1087-92. DOI: 10.1016/j.rmed.2004.03.025. View

Baughman R . Technical aspects of bronchoalveolar lavage: recommendations for a standard procedure. Semin Respir Crit Care Med. 2007; 28(5):475-85. DOI: 10.1055/s-2007-991520. View

Costabel U, Ohshimo S, Guzman J . Diagnosis of sarcoidosis. Curr Opin Pulm Med. 2008; 14(5):455-61. DOI: 10.1097/MCP.0b013e3283056a61. View

Bozinovski S, Jones J, Beavitt S, Cook A, Hamilton J, Anderson G . Innate immune responses to LPS in mouse lung are suppressed and reversed by neutralization of GM-CSF via repression of TLR-4. Am J Physiol Lung Cell Mol Physiol. 2003; 286(4):L877-85. DOI: 10.1152/ajplung.00275.2003. View

Lampi J, Roponen M, Hyvarinen A, Hirvonen M, Larsson L, Nevalainen A . Determinants of stimulated peripheral blood cytokine production among farming women. Int J Hyg Environ Health. 2011; 214(3):205-9. DOI: 10.1016/j.ijheh.2011.01.007. View

Szponar B, Pehrson C, Larsson L . Bacterial and fungal markers in tobacco smoke. Sci Total Environ. 2012; 438:447-51. DOI: 10.1016/j.scitotenv.2012.08.067. View

Domagala-Kulawik J . BAL in the diagnosis of smoking-related interstitial lung diseases: review of literature and analysis of our experience. Diagn Cytopathol. 2008; 36(12):909-15. DOI: 10.1002/dc.20944. View

10.

Karkkainen P, Valkonen M, Hyvarinen A, Nevalainen A, Rintala H . Determination of bacterial load in house dust using qPCR, chemical markers and culture. J Environ Monit. 2010; 12(3):759-68. DOI: 10.1039/b917937b. View

11.

Gorska K, Krenke R, Korczynski P, Kosciuch J, Domagala-Kulawik J, Chazan R . Eosinophilic airway inflammation in chronic obstructive pulmonary disease and asthma. J Physiol Pharmacol. 2009; 59 Suppl 6:261-70. View

12.

Krasnik L, Szponar B, Walczak M, Larsson L, Gamian A . Routine clinical laboratory tests correspond to increased serum levels of 3-hydroxy fatty acids, markers of endotoxins, in cardiosurgery patients. Arch Immunol Ther Exp (Warsz). 2006; 54(1):55-60. DOI: 10.1007/s00005-006-0006-2. View

13.

Michel O, Nagy A, Schroeven M, Duchateau J, Neve J, Fondu P . Dose-response relationship to inhaled endotoxin in normal subjects. Am J Respir Crit Care Med. 1997; 156(4 Pt 1):1157-64. DOI: 10.1164/ajrccm.156.4.97-02002. View

14.

Patel A, Ryu J, Reed C . Hypersensitivity pneumonitis: current concepts and future questions. J Allergy Clin Immunol. 2001; 108(5):661-70. DOI: 10.1067/mai.2001.119570. View

15.

Meyer K . Bronchoalveolar lavage as a diagnostic tool. Semin Respir Crit Care Med. 2007; 28(5):546-60. DOI: 10.1055/s-2007-991527. View

16.

Ferrando R, Szponar B, Sanchez A, Larsson L, Valero-Guillen P . 3-Hydroxy fatty acids in saliva as diagnostic markers in chronic periodontitis. J Microbiol Methods. 2005; 62(3):285-91. DOI: 10.1016/j.mimet.2005.04.014. View

17.

Hines C, Milton D, Larsson L, Petersen M, Fisk W, Mendell M . Characterization and variability of endotoxin and 3-hydroxy fatty acids in an office building during a particle intervention study. Indoor Air. 2000; 10(1):2-12. DOI: 10.1034/j.1600-0668.2000.010001002.x. View

18.

Cooke K, Kobzik L, Martin T, Brewer J, Delmonte Jr J, Crawford J . An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood. 1996; 88(8):3230-9. View

19.

Facco M, Cabrelle A, Teramo A, Olivieri V, Gnoato M, Teolato S . Sarcoidosis is a Th1/Th17 multisystem disorder. Thorax. 2010; 66(2):144-50. DOI: 10.1136/thx.2010.140319. View

20.

Larsson L, Saraf A . Use of gas chromatography-ion trap tandem mass spectrometry for the detection and characterization of microorganisms in complex samples. Mol Biotechnol. 1997; 7(3):279-87. DOI: 10.1007/BF02740818. View